Suzuken stock (JP3937600000): Recent price dip amid trading activity

Suzuken Co Ltd shares closed down 0.63% at 5,370 JPY on May 11, 2026, on the Tokyo Stock Exchange, according to JPX data.

Suzuken Co Ltd, a major Japanese pharmaceutical wholesaler, saw its stock decline by 34 JPY, or 0.63%, to close at 5,370 JPY on May 11, 2026. The shares traded in a range of 5,318 to 5,377 JPY during the session, as reported in the official JPX daily equity market report JPX as of 05/11/2026. This modest pullback comes amid ongoing market activity for the company, which plays a key role in Japan's healthcare distribution.

As of: 12.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Suzuken Co., Ltd.
• Sector/industry: Pharmaceutical wholesale
• Headquarters/country: Japan
• Core markets: Japan
• Key revenue drivers: Drug distribution, medical supplies
• Home exchange/listing venue: Tokyo Stock Exchange (TSE: 9987)
• Trading currency: JPY

Suzuken: core business model

Suzuken operates as one of Japan's leading pharmaceutical wholesalers, distributing prescription drugs, over-the-counter medicines, and medical devices to hospitals, clinics, and pharmacies across the country. The company sources products from manufacturers and ensures timely delivery through an extensive logistics network. This model positions Suzuken at the center of Japan's healthcare supply chain, handling a significant portion of the nation's pharmaceutical distribution.

Main revenue and product drivers for Suzuken

The bulk of Suzuken's revenue stems from wholesaling branded and generic pharmaceuticals, with additional contributions from medical equipment and healthcare services. In recent fiscal periods, the company has emphasized efficiency in its supply chain to counter pricing pressures in the sector. Drug distribution remains the primary driver, supported by stable demand from Japan's aging population.

Conclusion

Suzuken continues to serve as a vital link in Japan's pharmaceutical supply chain, with recent trading showing a minor dip on May 11, 2026. The company's focus on distribution efficiency supports its operations amid sector challenges. US investors tracking global healthcare plays may note its exposure to Japan's stable medical demand.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.